Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

BIO-Key International Company

BKYI
US09060C4087
A2QJDQ

Price

0.69
Today +/-
+0.02
Today %
+2.54 %
P

BIO-Key International stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the BIO-Key International stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the BIO-Key International stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the BIO-Key International stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze BIO-Key International's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

BIO-Key International Stock Price History

DateBIO-Key International Price
10/18/20240.69 undefined
10/17/20240.68 undefined
10/16/20240.70 undefined
10/15/20240.59 undefined
10/14/20240.65 undefined
10/11/20240.67 undefined
10/10/20240.65 undefined
10/9/20240.68 undefined
10/8/20240.71 undefined
10/7/20240.74 undefined
10/4/20240.84 undefined
10/3/20240.71 undefined
10/2/20240.87 undefined
10/1/20240.84 undefined
9/30/20240.96 undefined
9/27/20240.99 undefined
9/26/20241.04 undefined
9/25/20241.00 undefined
9/24/20241.08 undefined
9/23/20241.11 undefined

BIO-Key International Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into BIO-Key International, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by BIO-Key International from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects BIO-Key International’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of BIO-Key International. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into BIO-Key International’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing BIO-Key International’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on BIO-Key International’s growth potential.

BIO-Key International Revenue, EBIT and net profit per share

DateBIO-Key International RevenueBIO-Key International EBITBIO-Key International Net Income
2025e8.67 M undefined-2.92 M undefined-4.51 M undefined
2024e6.96 M undefined-4.03 M undefined-6.85 M undefined
20237.75 M undefined-8.83 M undefined-8.52 M undefined
20227.02 M undefined-8.03 M undefined-11.91 M undefined
20215.11 M undefined-4.94 M undefined-5.07 M undefined
20202.84 M undefined-5.2 M undefined-9.79 M undefined
20192.27 M undefined-6.56 M undefined-14.59 M undefined
20184.04 M undefined-6.87 M undefined-8.5 M undefined
20176.3 M undefined-4.28 M undefined-5.04 M undefined
20162.98 M undefined-4.2 M undefined-4.99 M undefined
20155.26 M undefined-1.7 M undefined-1.99 M undefined
20144.01 M undefined-2.04 M undefined-1.88 M undefined
20131.99 M undefined-2.52 M undefined-2.58 M undefined
20123.84 M undefined30,000 undefined0 undefined
20113.51 M undefined-1.45 M undefined-1.9 M undefined
20103.52 M undefined-1.2 M undefined-950,000 undefined
20092.36 M undefined-2.46 M undefined4.17 M undefined
20083.38 M undefined-1.69 M undefined-1.77 M undefined
20079.99 M undefined-5.37 M undefined-2.95 M undefined
200611.29 M undefined-6.67 M undefined-12.12 M undefined
200514.23 M undefined-8.29 M undefined-3.99 M undefined
20045.72 M undefined-6.44 M undefined-11.23 M undefined

BIO-Key International Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e
0000000000514119323331452642257768
-----------180.00-21.43-18.18-66.67-33.3350.00---66.67300.0025.00-60.00200.00-33.33-50.00-150.0040.00--14.2933.33
----------60.0071.4372.7388.89100.0050.0066.6766.67100.00100.0075.0060.00100.0050.00--100.0060.0057.1414.29--
000000000031088312231332300234100
000-2-5-3-2-2-2-3-6-8-6-5-1-2-1-10-2-2-1-4-4-6-6-5-4-8-8-4-2
-----------120.00-57.14-54.55-55.56-33.33-100.00-33.33-33.33--200.00-50.00-20.00-200.00-66.67-150.00-300.00-250.00-80.00-114.29-114.29-66.67-25.00
000-2-5-3-3-2-4-4-11-3-12-2-140-10-2-1-1-4-5-8-14-9-5-11-8-6-4
----150.00-40.00--33.33100.00-175.00-72.73300.00-83.33-50.00-500.00-----50.00-300.0025.0060.0075.00-35.71-44.44120.00-27.27-25.00-33.33
0.030.020.020.040.040.040.050.060.070.090.180.230.260.310.330.380.410.410.410.480.620.690.70.831.451.784.77.798.10.5600
--------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The BIO-Key International Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the BIO-Key International is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (k)LONG-T. INVEST. (k)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (k)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
19951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                         
0.010.093.351.060.10.050.520.021.011.961.420.630.971.710.791.010.040.082.020.844.321.060.290.320.5917.517.752.640.51
000.060.050.010.0100.070.11.921.843.162.130.10.850.350.590.60.280.633.391.562.881.570.130.550.971.521.2
0000000000.0300001.352.2600.190.010.070.040.060.110.060.110.350.130.050.1
0.010.110.470.410.030000.070.030.010.020.010.010.010.010.0100.010.010.350.470.9510.430.334.944.430.45
0.010.010.110.120.040.020.210.050.176.44.461.370.510.860.150.10.060.030.070.245.11.772.791.280.110.20.220.340.36
0.030.213.991.640.180.080.730.141.3510.347.735.183.622.683.153.730.70.92.391.7913.24.927.024.231.3718.9414.018.982.62
10401601408030006064055043018030403050201301006070180150660570320300257.08
0000000000000000000000000045000
0000000000000000000001.570.760000.1100
00.010.010.0100.020.030.040.074.13.32.511.320.250.230.220.210.20.170.167.1510.738.116.990.231.571.351.761.41
00000000012.0211.3911.397.840000000000001.261.2600
00.150.010.380.090.030.020.080.084.433.390.970.498.282.671.340.010.010.010.010.010.010.010.330.240.170.260.290.23
0.010.20.180.530.170.080.050.120.2121.1918.6315.39.838.562.941.590.270.230.310.277.2212.389.067.471.133.573.752.351.89
0.040.414.172.170.350.160.780.261.5631.5326.3620.4813.4511.246.095.320.971.132.72.0620.4217.316.0811.72.522.5117.7611.334.52
                                                         
0.020.050.080.080.090.10.130.140.210.410.016.076.677.522.640.010.010.010.010.010.0100000000
00.97.248.9611.4713.1315.5416.2818.3345.148.9251.0952.1351.6951.1950.9651.0151.0655.9257.5176.7578.2580.8385.687.44119.84120.19122.03126.05
-0.15-0.99-3.58-9.54-13.25-16.52-19.56-23.61-27.91-38.96-42.76-53.84-54.9-54.78-50.09-50.39-52.29-52.29-54.87-56.75-58.61-62.8-67.08-75.13-89.72-99.51-104.58-116.49-125.01
0-110-90-6000000000000000000000000-24022.82
00000000000000000000000000000
-0.13-0.153.65-0.56-1.69-3.29-3.89-7.19-9.376.556.173.323.94.433.740.58-1.27-1.221.060.7718.1515.4513.7510.47-2.2820.3315.615.31.06
0.010.220.290.280.340.330.240.360.351.350.831.221.160.250.340.180.690.930.540.351.160.470.50.480.920.240.431.111.32
00.010.240.20.441.120.090.570.164.65.524.693.40.660.580.950.670.590.330.490.630.340.690.550.860.741.011.171.34
0000.0300000.044.333.745.524.845.880.890.410.530.510.530.480.481.031.140.20.360.660.570.460.41
0.140.33000.151.4000000000.472.10.350.320000002.260.2302.60
0002.2100.606.5103.068.072.390000000000000000.120.14
0.150.560.532.720.933.450.337.440.5513.3418.1613.829.46.792.283.642.242.351.41.322.271.842.331.234.41.872.015.463.21
00001.1104.33010.3710.27000000000000000000.330.19
00000000000000000000000000017023
0000000001.382.033.340.140.030.071.11000.24000000.390.310.150.090.03
00001.1104.33010.3711.652.033.340.140.030.071.11000.24000000.390.310.150.590.24
0.150.560.532.722.043.454.667.4410.9224.9920.1917.169.546.822.354.752.242.351.641.322.271.842.331.234.792.182.166.053.45
0.020.414.182.160.350.160.770.251.5531.5426.3620.4813.4411.256.095.330.971.132.72.0920.4217.2916.0811.72.5122.5117.7711.354.52
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of BIO-Key International provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand BIO-Key International's financial health and stability.

Assets

BIO-Key International's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that BIO-Key International must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of BIO-Key International after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into BIO-Key International's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (k)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (k)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022
000-2-5-3-3-2-4-4-10-3-11-1040-10-2-1-1-4-4-6-14-9-5-11
000000000001,00001,0000000000001,0001,0000000
00000000000000000000000000000
000000000022210-100000-2-1-102-1-50
00001000112-54-30-400000-110129515
0000000000001,0000000000000000000
00000000000000000000000000000
000-2-4-2-1-1-2-2-5-4-3-20-1000-2-2-15-4-2-1-1-4-8-6
00000000000000000000000000000
0000000000-15107060300000000-200
0000000000-14107060300000000-200
00000000000000000000000000000
00001012131020-40-20-300000002001
0006000000110100-4000511912102700
00062112132031-40-60-30411911122401
---------------------------2.00--
00000000000000000000000000000
0003-2000000000000001-13-300016-9-5
0-0.16-0.72-2.81-4.59-2.2-1.72-1.93-2.26-2.93-5.93-4.66-3.67-2.210.13-1.69-0.32-0.580.07-2.81-2.52-15.56-4.5-2.64-1.66-1.88-4.99-9.02-6.31
00000000000000000000000000000

BIO-Key International stock margins

The BIO-Key International margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BIO-Key International. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BIO-Key International.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the BIO-Key International's sales revenue. A higher gross margin percentage indicates that the BIO-Key International retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the BIO-Key International's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the BIO-Key International's total revenue generated. When comparing the revenue margin year over year, investors can gauge the BIO-Key International's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the BIO-Key International. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the BIO-Key International's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

BIO-Key International Margin History

BIO-Key International Gross marginBIO-Key International Profit marginBIO-Key International EBIT marginBIO-Key International Profit margin
2025e18.46 %-33.65 %-52.06 %
2024e18.46 %-57.92 %-98.43 %
202318.46 %-113.82 %-109.89 %
202265.24 %-114.39 %-169.66 %
202167.32 %-96.67 %-99.22 %
202071.83 %-183.1 %-344.72 %
2019-8.37 %-288.99 %-642.73 %
2018-2.97 %-170.05 %-210.4 %
201748.57 %-67.94 %-80 %
201675.5 %-140.94 %-167.45 %
201575.67 %-32.32 %-37.83 %
201481.3 %-50.87 %-46.88 %
201380.4 %-126.63 %-129.65 %
201284.9 %0.78 %0 %
201176.92 %-41.31 %-54.13 %
201084.09 %-34.09 %-26.99 %
200978.39 %-104.24 %176.69 %
200890.24 %-50 %-52.37 %
200782.18 %-53.75 %-29.53 %
200674.93 %-59.08 %-107.35 %
200572.94 %-58.26 %-28.04 %
200463.99 %-112.59 %-196.33 %

BIO-Key International Stock Sales Revenue, EBIT, Earnings per Share

The BIO-Key International earnings per share therefore indicates how much revenue BIO-Key International has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue BIO-Key International earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates BIO-Key International's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of BIO-Key International’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating BIO-Key International's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

BIO-Key International Revenue, EBIT and net profit per share

DateBIO-Key International Sales per ShareBIO-Key International EBIT per shareBIO-Key International Earnings per Share
2025e2.88 undefined0 undefined-1.5 undefined
2024e2.31 undefined0 undefined-2.27 undefined
202313.84 undefined-15.75 undefined-15.21 undefined
20220.87 undefined-0.99 undefined-1.47 undefined
20210.66 undefined-0.63 undefined-0.65 undefined
20200.6 undefined-1.11 undefined-2.08 undefined
20191.28 undefined-3.69 undefined-8.2 undefined
20182.79 undefined-4.74 undefined-5.86 undefined
20177.59 undefined-5.16 undefined-6.07 undefined
20164.26 undefined-6 undefined-7.13 undefined
20157.62 undefined-2.46 undefined-2.88 undefined
20146.47 undefined-3.29 undefined-3.03 undefined
20134.15 undefined-5.25 undefined-5.38 undefined
20129.37 undefined0.07 undefined0 undefined
20118.56 undefined-3.54 undefined-4.63 undefined
20108.59 undefined-2.93 undefined-2.32 undefined
20096.21 undefined-6.47 undefined10.97 undefined
200810.24 undefined-5.12 undefined-5.36 undefined
200732.23 undefined-17.32 undefined-9.52 undefined
200643.42 undefined-25.65 undefined-46.62 undefined
200561.87 undefined-36.04 undefined-17.35 undefined
200431.78 undefined-35.78 undefined-62.39 undefined

BIO-Key International business model

BIO-Key International Inc. is a company specializing in biometric authentication and security solutions. It was founded in 1993 as a biometric research laboratory and has since become a leading provider of biometric authentication and security solutions worldwide. The company's business model consists of developing and selling biometric authentication and security solutions. It offers a wide range of products for various industries and customers, including businesses, government agencies, and the military. Some of its products include fingerprint-based authentication, facial recognition, iris scanner technologies, and software solutions such as ID Director. BIO-Key has expanded its offerings to include biometric-based hardware products such as fingerprint scanners for kiosks and ATMs, as well as biometric access control systems for offices and buildings. The company also specializes in Identity and Access Management (IAM) solutions. It is headquartered in Wall, New Jersey, operates offices in Europe and other continents, and is listed on the American stock exchange. Due to its technical capabilities, innovation, and market-oriented approach, BIO-Key is well-positioned to continue playing a leading role in the field of biometric authentication and security solutions in the future. BIO-Key International is one of the most popular companies on Eulerpool.com.

BIO-Key International SWOT Analysis

Strengths

1. Advanced Biometric Security Solutions: BIO-Key International Inc specializes in developing and providing advanced biometric security solutions, which are in high demand due to increasing concerns regarding cybersecurity.

2. Strong Intellectual Property Portfolio: The company holds a robust intellectual property portfolio associated with biometric technologies, enabling them to provide unique and innovative solutions to their clients.

3. Established Customer Base: BIO-Key has a solid customer base that includes organizations across various industries such as government, healthcare, financial services, and technology. This provides a stable revenue stream and opportunities for further growth.

Weaknesses

1. Dependency on Key Customers: BIO-Key's revenue heavily depends on a few key customers. Losing any of these customers could have a significant negative impact on the company's financial performance.

2. Limited Global Presence: The company mainly operates within the United States, which limits its exposure to international markets. Expanding their presence globally could lead to further growth opportunities.

3. Relatively Small Size: Compared to some of its competitors, BIO-Key International Inc is a relatively small company. This might make it challenging to compete with larger players in terms of resources, marketing, and brand recognition.

Opportunities

1. Increasing Demand for Biometric Security: With the growing number of cybersecurity threats and the need for enhanced authentication methods, there is a significant opportunity for BIO-Key to capture a larger market share.

2. Expansion into New Markets: By expanding their geographical presence and targeting new industries, such as retail and transportation, BIO-Key can diversify its customer base and revenue streams.

3. Partnerships and Collaborations: Forming strategic partnerships and collaborations with other technology companies or security providers can help BIO-Key expand its product offerings and reach a wider customer base.

Threats

1. Intense Competition: The biometric security market is highly competitive, with numerous established and emerging players. BIO-Key faces the risk of losing market share to competitors offering similar or more compelling solutions.

2. Technological Advancements: As technology evolves, there is a risk that BIO-Key's products and solutions may become obsolete or less relevant. It's crucial for the company to continually invest in research and development to stay ahead of technological changes.

3. Regulatory Challenges: Changes in government regulations related to biometric data collection and usage can impact BIO-Key's operations and require compliance adaptations, leading to potential delays and additional costs.

BIO-Key International Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

BIO-Key International historical P/E ratio, EBIT multiple, and P/S ratio

BIO-Key International shares outstanding

The number of shares was BIO-Key International in 2023 — This indicates how many shares 560,280 is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue BIO-Key International earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates BIO-Key International's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of BIO-Key International’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating BIO-Key International's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

BIO-Key International stock splits

In BIO-Key International's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for BIO-Key International.

BIO-Key International latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2024-0.55 -1  (-81.55 %)2024 Q2
6/30/2023-4.22 -2.88  (31.8 %)2023 Q2
3/31/2023-4.96 -1.44  (70.95 %)2023 Q1
12/31/2022-4.96 -7.2  (-45.24 %)2022 Q4
9/30/2022-0.16 -0.29  (-77.7 %)2022 Q3
6/30/2022-0.08 -0.21  (-157.35 %)2022 Q2
3/31/2022-0.22 -0.12  (46.52 %)2022 Q1
12/31/2021-0.15 -0.26  (-69.93 %)2021 Q4
9/30/2021-0.11 -0.13  (-15.86 %)2021 Q3
6/30/2021-0.11 -0.15  (-33.69 %)2021 Q2
1
2
3

BIO-Key International shareholders

%
Name
Stocks
Change
Date
2.17056 % Armistice Capital LLC65,33465,33412/31/2023
1.03797 % Kwok (Fong Wong)31,243010/31/2023
0.86834 % AJB Capital Investments LLC26,137-12,75212/31/2023
0.80000 % Sullivan (James David)24,08013912/29/2023
0.59754 % DePasquale (Michael W)17,9861,25012/29/2023
0.20515 % Tower Research Capital LLC6,1756,01212/31/2023
0.14189 % Welch (Cecilia C)4,271010/31/2023
0.11581 % Michel (Robert J)3,4861,4293/27/2024
0.10575 % Alia (Emmanuel)3,1831,4293/27/2024
0.07269 % LaCous (Mira K)2,18813912/29/2023
1
2
3
4

BIO-Key International Executives and Management Board

Mr. James Sullivan55
BIO-Key International Senior Vice President - Strategy and Compliance, Chief Legal Officer
Compensation 431,990
Mr. Michael DePasquale68
BIO-Key International Chairman of the Board, Chief Executive Officer (since 2003)
Compensation 372,080
Ms. Mira LaCous61
BIO-Key International Chief Technology Officer
Compensation 240,426
Ms. Cecilia Welch63
BIO-Key International Chief Financial Officer
Compensation 202,077
Mr. Emmanuel Alia58
BIO-Key International Independent Director
Compensation 16,008
1
2

BIO-Key International Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Amazon.com Stock
Amazon.com
SupplierCustomer0,840,890,230,320,47-0,21
Allscripts Healthcare Sol Stock
Allscripts Healthcare Sol
SupplierCustomer0,750,880,630,22-0,59-0,71
Broadcom Stock
Broadcom
SupplierCustomer0,740,620,660,46-0,81-0,80
Oracle Stock
Oracle
SupplierCustomer0,740,88-0,010,150,18-0,63
Insight Enterprises Stock
Insight Enterprises
SupplierCustomer0,550,690,750,55-0,33-0,70
IBM Stock
IBM
SupplierCustomer0,550,47-0,31-0,300,25-0,37
HNA Technology A Stock
HNA Technology A
SupplierCustomer0,530,290,660,400,570,15
NCR Stock
NCR
SupplierCustomer0,450,570,600,500,65-0,54
Microsoft Stock
Microsoft
SupplierCustomer0,390,310,060,20-0,53-0,73
Atlassian A Stock
Atlassian A
SupplierCustomer0,340,790,710,500,33-0,46
1
2

Most common questions regarding BIO-Key International

What values and corporate philosophy does BIO-Key International represent?

BIO-Key International Inc represents a set of core values and a corporate philosophy centered on innovation, security, and reliability. As a leading provider of biometric authentication solutions, BIO-Key's commitment to cutting-edge technology and data protection sets them apart in the industry. Their solutions leverage advanced biometric algorithms, ensuring the highest level of security for individuals and organizations. With a focus on delivering dependable and user-friendly authentication methods, BIO-Key strives to enhance privacy and streamline access control measures. Through their ongoing dedication to excellence, BIO-Key International Inc aims to empower users and protect sensitive data across various industries.

In which countries and regions is BIO-Key International primarily present?

BIO-Key International Inc primarily operates in the United States.

What significant milestones has the company BIO-Key International achieved?

Some significant milestones achieved by BIO-Key International Inc include: - The company's partnership with Microsoft, which has enabled BIO-Key to integrate its fingerprint biometric technology with Microsoft's cloud services. - The development of innovative biometric authentication solutions for mobile devices, such as its MobileAuth app that provides secure access to mobile applications and websites. - BIO-Key's collaboration with various government agencies and organizations to enhance security measures and protect sensitive data. - The company's expansion into international markets, with a focus on Europe, Asia, and the Middle East, establishing a global footprint in the biometric security industry. - BIO-Key's consistent growth and success in securing major contracts and partnerships, further establishing its position as a leading provider of biometric authentication solutions.

What is the history and background of the company BIO-Key International?

BIO-Key International Inc is a renowned global leader in biometric authentication solutions. Founded in 1993, the company has a rich history of developing innovative technologies for secure and convenient user authentication. With a focus on fingerprint-based biometric identification, BIO-Key has successfully provided advanced solutions to various industries, including healthcare, finance, government, and enterprise. The company's commitment to continuous research and development has earned them a reputation for cutting-edge biometric technology and software solutions. BIO-Key International Inc continually strives to enhance security measures and revolutionize the way organizations protect sensitive information and maintain a secure environment.

Who are the main competitors of BIO-Key International in the market?

The main competitors of BIO-Key International Inc in the market include companies such as Idex Biometrics ASA, Crossmatch Technologies, and Nuance Communications Inc.

In which industries is BIO-Key International primarily active?

BIO-Key International Inc primarily operates in the biometric technology industry.

What is the business model of BIO-Key International?

The business model of BIO-Key International Inc revolves around offering advanced biometric authentication solutions. BIO-Key specializes in developing and providing fingerprint and multi-factor authentication technologies to enhance security in various industries. Their solutions are designed to cater to enterprise, government, and consumer markets, offering secure access to data and systems. BIO-Key's biometric authentication software and hardware enable organizations to prevent identity theft, reduce fraud, and enhance overall security measures. With a focus on providing convenient and reliable biometric solutions, BIO-Key International Inc aims to revolutionize the way authentication is implemented and ensure a safer digital environment.

What is the P/E ratio of BIO-Key International 2024?

The BIO-Key International P/E ratio is -0.06.

What is the P/S ratio of BIO-Key International 2024?

The BIO-Key International P/S ratio is 0.06.

What is the Quality Investing of BIO-Key International?

The Quality Investing for BIO-Key International is 6/10.

What is the revenue of BIO-Key International 2024?

The expected BIO-Key International revenue is 6.96 M USD.

How high is the profit of BIO-Key International 2024?

The expected BIO-Key International profit is -6.85 M USD.

What is the business model of BIO-Key International

BIO-Key International Inc. is an American company specializing in the development and delivery of biometric identity management systems (BIMS). They offer software, hardware, and biometric solutions tailored to meet the individual needs of their customers. The company works closely with industry experts and government agencies to ensure their products and solutions meet the highest standards. Their goal is to help businesses protect their IT infrastructure and minimize security risks. BIO-Key International is a trusted partner for government agencies and military organizations in the US and worldwide. Their products and solutions are designed to enhance security and efficiency for businesses of all sizes and industries.

What is the BIO-Key International dividend?

BIO-Key International pays a dividend of 0 USD distributed over payouts per year.

How often does BIO-Key International pay dividends?

The dividend cannot currently be calculated for BIO-Key International or the company does not pay out a dividend.

What is the BIO-Key International ISIN?

The ISIN of BIO-Key International is US09060C4087.

What is the BIO-Key International WKN?

The WKN of BIO-Key International is A2QJDQ.

What is the BIO-Key International ticker?

The ticker of BIO-Key International is BKYI.

How much dividend does BIO-Key International pay?

Over the past 12 months, BIO-Key International paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BIO-Key International is expected to pay a dividend of 0 USD.

What is the dividend yield of BIO-Key International?

The current dividend yield of BIO-Key International is .

When does BIO-Key International pay dividends?

BIO-Key International pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BIO-Key International?

BIO-Key International paid dividends every year for the past 0 years.

What is the dividend of BIO-Key International?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is BIO-Key International located?

BIO-Key International is assigned to the 'Information technology' sector.

Wann musste ich die Aktien von BIO-Key International kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BIO-Key International from 10/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/21/2024.

When did BIO-Key International pay the last dividend?

The last dividend was paid out on 10/21/2024.

What was the dividend of BIO-Key International in the year 2023?

In the year 2023, BIO-Key International distributed 0 USD as dividends.

In which currency does BIO-Key International pay out the dividend?

The dividends of BIO-Key International are distributed in USD.

All fundamentals about BIO-Key International

Our stock analysis for BIO-Key International Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BIO-Key International Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.